TABLE 6.
Preoperative characteristics n (%), m (SD) | HM3 (n 49) | HVAD (n 54) | p |
---|---|---|---|
Age, years | 66.2 (5.6) | 67.5 (5.02) | 0.18 |
Sex, males | 43 (87.8) | 46 (85.2) | 0.7 |
BSA, cm/m2 | 1.9 (0.16) | 1.8 (0.15) | 0.21 |
Creatinine, mg/dL | 1.6 (0.76) | 1.5 (0.45) | 0.65 |
AST, U/L | 33.09 (34.4) | 41.6 (59.4) | 0.39 |
ALT, U/L | 26.1 (14.9) | 38.8 (37.9) | 0.03 |
Atrial fibrillation | 15(30.6) | 12 (22.2) | 0.33 |
EF, % | 18.9 (6.4) | 18.9 (5.7) | 0.98 |
LVEDV, mL | 247.12 (94.2) | 272. 5 (94.2) | 0.26 |
TAPSE, mm | 16.9 (4.03) | 17.5 (5.3) | 0.55 |
PVR (Fick), wood | 2.7 (1.3) | 3.1 (2.1) | 0.19 |
Cardiac index (Fick) | 2.2 (0.65) | 2.13 (0.57) | 0.5 |
sPAP, mmHg | 43.04 (15.5) | 40.4 (15.2) | 0.38 |
Heart disease | 0.41 | ||
Idiopathic | 16 (32.7) | 25 (46.3) | |
Hypertrophic | 0 | 0 | |
Ischaemic | 31 (63.3) | 28 (51.9) | |
Other | 1 (2) | 1 (1.9) | |
Intermacs | 0.21 | ||
1 | 3 (6.1) | 1 (1.9) | |
2 | 7 (14.3) | 16 (29.6) | |
3 | 29 (59.9) | 29 (53.7) | |
4 | 10 (20.4) | 8 (7.8) | |
IABP | 20 (40.8) | 22 (40.7) | 0.99 |
VA-ECMO | 2 (4.1) | 5 (9.3) | 0.44 |
REDO | 5 (10.2) | 4 (7.4) | 0.73 |
BSA, body surface area; DT, destination therapy; EF, ejection fraction; IABP, intra-aortic balloon pump; LVEDV; center ventricular end diastolic volume; PAP, systolic pulmonary arterial pressure; PVR, pulmonary vascular resistance; VA-ECMO, veno-arterial extracorporeal membrane oxygenation
*Statistically significant.